Skip to main content

PagnatoKarp Partners LLC

Location
RESTON, VA
Portfolio Value
Small $114,457,571
Diversification
Moderately concentrated
Filing Date
Mar 31, 2020
Global Rank
#2,931 / 5,300
Top Industry
Drug Manufacturers - General 12.2%
3Y Alpha vs SPY
-1.8%
Period ended 6 years ago
Filed Apr 16, 2020 · 6y

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+68.5%
SPY
+76.3%
Annualised alpha
-1.8%
Max drawdown
−17.8%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

90 positions · as of Mar 31, 2020
Top Position
37.5%
of portfolio value
Top 5
54.8%
of portfolio value
Top 10
63.0%
of portfolio value
HHI
1,528
Moderately concentrated

Sector Breakdown

As of Mar 31, 2020
Sector % Portfolio Value
Unclassified 39.9% $45,687,551
Technology 19.1% $21,817,740
Financial Services 14.3% $16,325,665
Healthcare 9.2% $10,538,653
Communication Services 5.4% $6,223,365
Consumer Defensive 4.1% $4,680,991
Consumer Cyclical 2.8% $3,234,796
Industrials 2.8% $3,161,514
Energy 1.2% $1,329,801
Basic Materials 0.7% $813,107
Utilities 0.3% $362,309
Real Estate 0.2% $282,079

Portfolio Positions

Export CSV View 13F filing
90 positions · $114,457,571 total · as of Mar 31, 2020
Showing 1–50 of 90 positions by value · page 1 of 2
Ticker Company Shares Value (USD) % of Portfolio History